These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18725815)

  • 1. HIV and cardiometabolic abnormalities: new perspectives and treatment update.
    Tebas P
    J Acquir Immune Defic Syndr; 2008 Sep; 49 Suppl 2():S77-8. PubMed ID: 18725815
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV and antiretroviral therapy: lipid abnormalities and associated cardiovascular risk in HIV-infected patients.
    Kotler DP
    J Acquir Immune Defic Syndr; 2008 Sep; 49 Suppl 2():S79-85. PubMed ID: 18725816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
    Basile J; Houston M; Ferrario CM
    J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndrome.
    Robins SJ
    Curr Cardiol Rep; 2005 Nov; 7(6):457-64. PubMed ID: 16256016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune vasculitis and plaque erosion in the cardiometabolic syndrome and type 2 diabetes mellitus.
    Hayden MR; Karuparthi PR; Chowdhury NA; Govindarajan G; Habibi J; Ortmann RA
    J Cardiometab Syndr; 2006; 1(3):228-32. PubMed ID: 17679803
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.
    Ferdinand KC
    J Cardiometab Syndr; 2006; 1(2):133-40. PubMed ID: 17679832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular risk in HIV infected patients].
    Raimundo P; Miranda A; Ribeiro J; Mansinho K
    Acta Med Port; 2010; 23(4):669-76. PubMed ID: 20687996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent lipid abnormalities in diabetes; are we approaching the treatment optimally?
    Hitman GA
    Diabet Med; 2011 Nov; 28(11):1281. PubMed ID: 22004300
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal waist:height ratio cut-off point for cardiometabolic risk factors in Turkish adults.
    Can AS; Yildiz EA; Samur G; Rakicioğlu N; Pekcan G; Ozbayrakçi S; Palaoğlu KE; Gönen M; Bersot TP
    Public Health Nutr; 2010 Apr; 13(4):488-95. PubMed ID: 19781128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and morphologic complications of HIV infection.
    Eid AJ; Orenstein R
    J Med Liban; 2006; 54(2):97-105. PubMed ID: 17087001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on Pediatric Human Immunodeficiency Virus Infection: Paradigms in Treatment and Prevention.
    Smith C; McFarland EJ
    Adv Pediatr; 2016 Aug; 63(1):147-71. PubMed ID: 27426899
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular disease in HIV infection.
    Sánchez-Torres RJ; García-Palmieri MR
    P R Health Sci J; 2006 Sep; 25(3):249-54. PubMed ID: 17203795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High cardiovascular risk in patients with diabetes and the cardiometabolic syndrome: mandate for statin therapy.
    Gonzalez GL; Manrique CM; Sowers JR
    J Cardiometab Syndr; 2006; 1(3):178-83. PubMed ID: 17679817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The basis and management of metabolic abnormalities associated with cardiovascular risk in human immunodeficiency virus infection and its treatment.
    Crook M
    Ann Clin Biochem; 2007 May; 44(Pt 3):219-31. PubMed ID: 17456292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and cardiovascular disease: new perspectives.
    Peter R; Rees A
    Curr Opin Lipidol; 2009 Apr; 20(2):145-6. PubMed ID: 19276893
    [No Abstract]   [Full Text] [Related]  

  • 16. Diastolic dysfunction in the cardiometabolic syndrome.
    Karuparthi PR; Yerram P; Hayden MR
    J Cardiometab Syndr; 2006; 1(5):369-72. PubMed ID: 17679796
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome.
    Srikanth S; Deedwania P
    Curr Hypertens Rep; 2016 Oct; 18(10):76. PubMed ID: 27730495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic abnormalities, lipodystrophy and cardiovascular risk in HIV-infected patients].
    Leclercq P; Blanc M
    Rev Prat; 2006 May; 56(9):987-94. PubMed ID: 16775979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein abnormalities in patients with type 2 diabetes and metabolic syndrome.
    Dickson-Humphries T; Bottenberg B; Kuntz S
    JAAPA; 2013 Jul; 26(7):13-8. PubMed ID: 23923282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection.
    Barbaro G
    Curr HIV Res; 2006 Jan; 4(1):79-85. PubMed ID: 16454713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.